Authors
Loading...
Review reveals how statins alter l-mevalonate metabolites to modulate immune responses across inflammatory disorders, suggesting therapeutic potential without broad immune paralysis.
Robert Zeiser (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: